Takashi Ninomiya, Nobuhisa Ishikawa, Toshiyuki Kozuki, Shoichi Kuyama, Koji Inoue, Toshihide Yokoyama, Nobuhiro Kanaji, Masayuki Yasugi, Takuo Shibayama, Keisuke Aoe, et al. A randomized phase II study of afatinib alone or combined with bevacizumab for treating chemo-naïve patients with non-small cell lung cancer harboring EGFR mutations. Lung cancer (Amsterdam, Netherlands). 2023. 184. 107349-107349
Tetsuya Sakai, Shingo Matsumoto, Yasuto Ueda, Yuji Shibata, Takaya Ikeda, Atsushi Nakamura, Masahiro Kodani, Kadoaki Ohashi, Naoki Furuya, Hiroki Izumi, et al. Clinicogenomic Features and Targetable Mutations in NSCLCs Harboring BRAF Non-V600E Mutations: A Multi-Institutional Genomic Screening Study (LC-SCRUM-Asia). Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer. 2023. 18. 11. 1538-1549